1	Tumor	Tumor	B-NP	NN	O	2	NMOD	-1
2	Angiogenesis	Angiogenesis	I-NP	NN	O	9	NMOD	3	Angiogenesis
3	:	:	O	:	O	2	P	-1
4	Initiation	Initiation	B-NP	NN	O	9	NMOD	0
5	and	and	I-NP	CC	O	9	NMOD	-1
6	Targeting	Targeting	I-NP	NN	O	9	NMOD	0
7	-	-	B-NP	HYPH	O	9	NMOD	-1
8	Therapeutic	Therapeutic	I-NP	JJ	O	9	NMOD	-1
9	Targeting	Targeting	I-NP	NN	O	0	ROOT	0
10	of	of	B-PP	IN	O	9	NMOD	-1
11	an	an	B-NP	DT	O	13	NMOD	-1
12	FGF-Binding	FGF-Binding	I-NP	NN	B-protein	13	NMOD	-1
13	Protein	Protein	I-NP	NN	I-protein	21	NMOD	-1
14	,	,	O	,	O	21	P	-1
15	an	an	B-NP	DT	O	18	NMOD	-1
16	Angiogenic	Angiogenic	I-NP	JJ	O	18	NMOD	3	Angiogenic
17	Switch	Switch	I-NP	NNP	O	18	NMOD	-1
18	Molecule	Molecule	I-NP	NNP	O	21	NMOD	-1
19	,	,	O	,	O	21	P	-1
20	and	and	O	CC	O	21	NMOD	-1
21	Indicator	Indicator	B-NP	NN	O	10	PMOD	-1
22	of	of	B-PP	IN	O	21	NMOD	-1
23	Early	Early	B-NP	JJ	O	24	NMOD	-1
24	Stages	Stage	I-NP	NNS	O	22	PMOD	-1
25	of	of	B-PP	IN	O	24	NMOD	-1
26	Gastrointestinal	Gastrointestinal	B-NP	JJ	O	27	NMOD	-1
27	Adenocarcinomas	Adenocarcinoma	I-NP	NNS	O	25	PMOD	-1
28	-	-	B-ADJP	HYPH	O	9	P	-1
29	.	.	O	.	O	9	P	-1

1	Tumor	Tumor	B-NP	NN	O	2	NMOD	-1
2	angiogenesis	angiogenesis	I-NP	NN	O	3	SUB	3	angiogenesis
3	has	have	B-VP	VBZ	O	0	ROOT	-1
4	been	be	I-VP	VBN	O	3	VC	-1
5	related	relate	I-VP	VBN	O	12	NMOD	-1
6	to	to	B-PP	TO	O	5	AMOD	-1
7	the	the	B-NP	DT	O	8	NMOD	-1
8	initiation	initiation	I-NP	NN	O	6	PMOD	17	initiation
9	as	as	B-CONJP	RB	O	12	NMOD	-1
10	well	well	I-CONJP	RB	O	9	DEP	-1
11	as	as	I-CONJP	IN	O	9	DEP	-1
12	progression	progression	B-NP	NN	O	4	PRD	17	progression
13	toward	toward	B-PP	IN	O	12	NMOD	-1
14	more	more	B-NP	RBR	O	15	AMOD	-1
15	aggressive	aggressive	I-NP	JJ	O	16	NMOD	-1
16	behavior	behavior	I-NP	NN	O	13	PMOD	-1
17	of	of	B-PP	IN	O	16	NMOD	-1
18	human	human	B-NP	JJ	O	19	NMOD	-1
19	tumors	tumor	I-NP	NNS	O	17	PMOD	-1
20	.	.	O	.	O	3	P	-1

1	In	In	B-PP	IN	O	9	VMOD	-1
2	particular	particular	B-NP	JJ	O	1	PMOD	-1
3	,	,	O	,	O	9	P	-1
4	the	the	B-NP	DT	O	5	NMOD	-1
5	activity	activity	I-NP	NN	O	9	SUB	0
6	of	of	B-PP	IN	O	5	NMOD	-1
7	angiogenic	angiogenic	B-NP	JJ	B-protein	8	NMOD	3	angiogenic
8	factors	factor	I-NP	NNS	I-protein	6	PMOD	-1
9	is	be	B-VP	VBZ	O	0	ROOT	-1
10	crucial	crucial	B-ADJP	JJ	O	9	PRD	-1
11	for	for	B-PP	IN	O	10	AMOD	-1
12	tumor	tumor	B-NP	NN	O	13	NMOD	-1
13	progression	progression	I-NP	NN	O	11	PMOD	2	progression
14	.	.	O	.	O	9	P	-1

1	We	We	B-NP	PRP	O	3	SUB	-1
2	previously	previously	B-ADVP	RB	O	3	VMOD	-1
3	characterized	characterize	B-VP	VBD	O	0	ROOT	-1
4	a	a	B-NP	DT	O	9	NMOD	-1
5	secreted	secrete	I-NP	VBN	O	9	NMOD	14	secreted
6	fibroblast	fibroblast	I-NP	NN	B-protein	9	NMOD	-1
7	growth	growth	I-NP	NN	I-protein	9	NMOD	0
8	factor-binding	factor-binding	I-NP	JJ	I-protein	9	NMOD	-1
9	protein	protein	I-NP	NN	I-protein	3	OBJ	-1
10	(	(	O	(	O	12	DEP	-1
11	FGF-BP	FGF-BP	B-NP	NN	B-protein	12	DEP	-1
12	)	)	O	)	O	9	NMOD	-1
13	as	as	B-PP	IN	O	3	VMOD	-1
14	a	a	B-NP	DT	O	16	NMOD	-1
15	chaperone	chaperone	I-NP	NN	B-protein	16	NMOD	-1
16	molecule	molecule	I-NP	NN	I-protein	24	SUB	-1
17	,	,	O	,	O	16	P	-1
18	which	which	B-NP	WDT	O	16	NMOD	-1
19	binds	bind	B-VP	VBZ	O	18	SBAR	0
20	to	to	B-PP	TO	O	19	VMOD	-1
21	various	various	B-NP	JJ	O	20	PMOD	15	various
22	FGFs	FGF	I-NP	NNS	B-protein	21	NMOD	-1
23	,	,	O	,	O	16	P	-1
24	enhances	enhance	B-VP	VBZ	O	13	SBAR	0
25	FGF-mediated	FGF-mediated	B-NP	JJ	O	29	NMOD	-1
26	biochemical	biochemical	I-NP	JJ	O	29	NMOD	-1
27	and	and	I-NP	CC	O	29	NMOD	-1
28	biologic	biologic	I-NP	JJ	O	29	NMOD	-1
29	events	event	I-NP	NNS	O	24	OBJ	-1
30	and	and	O	CC	O	24	VMOD	-1
31	importantly	importantly	B-VP	RB	O	24	VMOD	-1
32	is	be	I-VP	VBZ	O	24	VMOD	-1
33	a	a	B-NP	DT	O	36	NMOD	-1
34	crucial	crucial	I-NP	JJ	B-protein	36	NMOD	17	crucial
35	rate-limiting	rate-limiting	I-NP	JJ	I-protein	36	NMOD	-1
36	factor	factor	I-NP	NN	I-protein	32	PRD	-1
37	for	for	B-PP	IN	O	36	NMOD	-1
38	tumor-dependent	tumor-dependent	B-NP	JJ	O	39	NMOD	17	dependent
39	angiogenesis	angiogenesis	I-NP	NN	O	37	PMOD	3	angiogenesis
40	.	.	O	.	O	3	P	-1

1	We	We	B-NP	PRP	O	2	SUB	-1
2	generated	generate	B-VP	VBD	O	0	ROOT	19	generated
3	monoclonal	monoclonal	B-NP	JJ	B-protein	4	NMOD	-1
4	antibodies	antibody	I-NP	NNS	I-protein	2	OBJ	-1
5	that	that	B-NP	WDT	O	4	NMOD	-1
6	target	target	B-VP	VBP	O	5	SBAR	0
7	FGF-BP	FGF-BP	B-NP	NN	B-protein	8	NMOD	-1
8	protein	protein	I-NP	NN	I-protein	6	OBJ	-1
9	and	and	O	CC	O	2	VMOD	-1
10	used	use	B-VP	VBD	O	2	VMOD	0
11	them	them	B-NP	PRP	O	10	OBJ	-1
12	as	as	B-PP	IN	O	10	VMOD	-1
13	a	a	B-NP	DT	O	14	NMOD	-1
14	tool	tool	I-NP	NN	O	12	PMOD	-1
15	to	to	B-VP	TO	O	16	VMOD	-1
16	evaluate	evaluate	I-VP	VB	O	10	VMOD	-1
17	frequency	frequency	B-NP	NN	O	19	NMOD	-1
18	and	and	I-NP	CC	O	19	NMOD	-1
19	pattern	pattern	I-NP	NN	O	16	OBJ	-1
20	of	of	B-PP	IN	O	19	NMOD	-1
21	FGF-BP	FGF-BP	B-NP	NN	B-protein	22	NMOD	-1
22	expression	expression	I-NP	NN	O	20	PMOD	9	expression
23	during	during	B-PP	IN	O	19	NMOD	-1
24	the	the	B-NP	DT	O	26	NMOD	-1
25	malignant	malignant	I-NP	JJ	O	26	NMOD	-1
26	progression	progression	I-NP	NN	O	23	PMOD	2	progression
27	of	of	B-PP	IN	O	26	NMOD	-1
28	pancreas	pancreas	B-NP	NN	O	31	NMOD	-1
29	and	and	O	CC	O	31	NMOD	-1
30	colorectal	colorectal	B-NP	JJ	O	31	NMOD	-1
31	carcinoma	carcinoma	I-NP	NN	O	27	PMOD	-1
32	in	in	B-PP	IN	O	26	NMOD	-1
33	archival	archival	B-NP	JJ	O	35	NMOD	-1
34	tissue	tissue	I-NP	NN	O	35	NMOD	-1
35	samples	sample	I-NP	NNS	O	32	PMOD	-1
36	.	.	O	.	O	2	P	-1

1	We	We	B-NP	PRP	O	2	SUB	-1
2	found	find	B-VP	VBD	O	0	ROOT	0
3	that	that	B-SBAR	IN	O	2	VMOD	-1
4	FGF-BP	FGF-BP	B-NP	NN	B-protein	5	SUB	-1
5	is	be	B-VP	VBZ	O	3	SBAR	-1
6	dramatically	dramatically	I-VP	RB	O	5	VMOD	-1
7	upregulated	upregulate	I-VP	VBN	O	5	VC	17	upregulated
8	during	during	B-PP	IN	O	7	VMOD	-1
9	the	the	B-NP	DT	O	10	NMOD	-1
10	initiation	initiation	I-NP	NN	O	8	PMOD	2	initiation
11	of	of	B-PP	IN	O	10	NMOD	-1
12	colorectal	colorectal	B-NP	JJ	O	15	NMOD	-1
13	and	and	I-NP	CC	O	15	NMOD	-1
14	pancreatic	pancreatic	I-NP	JJ	O	15	NMOD	-1
15	adenocarcinoma	adenocarcinoma	I-NP	NN	O	11	PMOD	-1
16	.	.	O	.	O	2	P	-1

1	Crucial	Crucial	B-NP	JJ	O	3	NMOD	-1
2	genetic	genetic	I-NP	JJ	O	3	NMOD	-1
3	events	event	I-NP	NNS	O	26	SUB	-1
4	underlying	underlie	B-VP	VBG	O	3	NMOD	-1
5	the	the	B-NP	DT	O	8	NMOD	-1
6	initiation	initiation	I-NP	NN	O	8	NMOD	2	initiation
7	and	and	I-NP	CC	O	8	NMOD	-1
8	progression	progression	I-NP	NN	O	4	OBJ	2	progression
9	of	of	B-PP	IN	O	8	NMOD	-1
10	colorectal	colorectal	B-NP	JJ	O	12	AMOD	-1
11	and	and	I-NP	CC	O	12	AMOD	-1
12	pancreatic	pancreatic	I-NP	JJ	O	13	NMOD	-1
13	adenocarcinoma	adenocarcinoma	I-NP	NN	O	9	PMOD	-1
14	with	with	B-PP	IN	O	8	NMOD	-1
15	a	a	B-NP	DT	O	17	NMOD	-1
16	particular	particular	I-NP	JJ	O	17	NMOD	-1
17	focus	focus	I-NP	NN	O	14	PMOD	-1
18	on	on	B-PP	IN	O	17	NMOD	-1
19	the	the	B-NP	DT	O	20	NMOD	-1
20	modulation	modulation	I-NP	NN	O	18	PMOD	16	modulation
21	of	of	B-PP	IN	O	20	NMOD	-1
22	angiogenesis	angiogenesis	B-NP	NN	O	25	NMOD	3	angiogenesis
23	and	and	O	CC	O	25	NMOD	-1
24	antiangiogenic	antiangiogenic	B-NP	JJ	O	25	NMOD	3	angiogenic
25	therapies	therapy	I-NP	NNS	O	21	PMOD	19	therapies
26	are	be	B-VP	VBP	O	0	ROOT	-1
27	discussed	discuss	I-VP	VBN	O	26	VC	-1
28	.	.	O	.	O	26	P	-1

1	We	We	B-NP	PRP	O	2	SUB	-1
2	propose	propose	B-VP	VBP	O	0	ROOT	-1
3	that	that	B-SBAR	IN	O	2	VMOD	-1
4	the	the	B-NP	DT	O	5	NMOD	-1
5	upregulation	upregulation	I-NP	NN	O	19	SUB	17	upregulation
6	of	of	B-PP	IN	O	5	NMOD	-1
7	the	the	B-NP	DT	O	10	NMOD	-1
8	secreted	secrete	I-NP	VBN	O	10	NMOD	14	secreted
9	FGF-BP	FGF-BP	I-NP	NN	B-protein	10	NMOD	-1
10	protein	protein	I-NP	NN	I-protein	6	PMOD	-1
11	during	during	B-PP	IN	O	5	NMOD	-1
12	early	early	B-NP	JJ	O	13	NMOD	-1
13	phases	phase	I-NP	NNS	O	11	PMOD	-1
14	of	of	B-PP	IN	O	13	NMOD	-1
15	pancreas	pancreas	B-NP	NN	O	18	NMOD	-1
16	and	and	O	CC	O	18	NMOD	-1
17	colon	colon	B-NP	NN	O	18	NMOD	-1
18	cancer	cancer	I-NP	NN	O	14	PMOD	-1
19	could	could	B-VP	MD	O	3	SBAR	-1
20	make	make	I-VP	VB	O	19	VC	-1
21	this	this	B-NP	DT	O	22	NMOD	-1
22	protein	protein	I-NP	NN	O	20	OBJ	-1
23	a	a	B-NP	DT	O	26	NMOD	-1
24	possible	possible	I-NP	JJ	O	26	NMOD	-1
25	serum	serum	I-NP	NN	O	26	NMOD	-1
26	marker	marker	I-NP	NN	O	20	VMOD	-1
27	indicating	indicate	B-VP	VBG	O	26	NMOD	-1
28	the	the	B-NP	DT	O	29	NMOD	-1
29	presence	presence	I-NP	NN	O	27	OBJ	0
30	of	of	B-PP	IN	O	29	NMOD	-1
31	high-risk	high-risk	B-NP	JJ	O	33	NMOD	-1
32	premalignant	premalignant	I-NP	JJ	O	33	NMOD	-1
33	lesions	lesion	I-NP	NNS	O	30	PMOD	-1
34	.	.	O	.	O	2	P	-1

1	Furthermore	Furthermore	B-ADVP	RB	O	8	VMOD	-1
2	,	,	O	,	O	8	P	-1
3	the	the	B-NP	DT	O	5	NMOD	-1
4	biological	biological	I-NP	JJ	O	5	NMOD	-1
5	activity	activity	I-NP	NN	O	8	SUB	0
6	of	of	B-PP	IN	O	5	NMOD	-1
7	FGF-BP	FGF-BP	B-NP	NN	B-protein	6	PMOD	-1
8	is	be	B-VP	VBZ	O	0	ROOT	-1
9	neutralized	neutralize	I-VP	VBN	O	8	VC	-1
10	by	by	B-PP	IN	O	9	VMOD	-1
11	monoclonal	monoclonal	B-NP	JJ	B-protein	12	NMOD	-1
12	antibodies	antibody	I-NP	NNS	I-protein	10	PMOD	-1
13	suggesting	suggest	B-VP	VBG	O	12	NMOD	-1
14	the	the	B-NP	DT	O	15	NMOD	-1
15	potential	potential	I-NP	NN	O	13	OBJ	0
16	for	for	B-PP	IN	O	15	NMOD	-1
17	antibody-based	antibody-based	B-NP	JJ	O	18	AMOD	-1
18	therapeutic	therapeutic	I-NP	JJ	O	19	NMOD	-1
19	targeting	targeting	I-NP	NN	O	16	PMOD	0
20	.	.	O	.	O	8	P	-1

